BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8796544)

  • 1. Cost-effectiveness of image-guided core needle biopsy versus surgery in diagnosing breast cancer.
    Nields MW
    Acad Radiol; 1996 Apr; 3 Suppl 1():S138-40. PubMed ID: 8796544
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost evaluation of breast cancer screening in France.
    Lamarque JL; Pujol J; Cherifcheikh J; Laurent JC; Taourel P; Boulet P; Daurès JP; Séguret F; Guizard AV; Delande G; Negre M
    Acad Radiol; 1998 Sep; 5 Suppl 2():S336-9. PubMed ID: 9750847
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of stereotaxic breast core needle biopsy.
    Fajardo LL
    Acad Radiol; 1996 Apr; 3 Suppl 1():S21-3. PubMed ID: 8796501
    [No Abstract]   [Full Text] [Related]  

  • 4. Regarding trends in recall, biopsy, and positive biopsy rates for screening mammography.
    Ellis RL
    Radiology; 2006 Jan; 238(1):375-6; author reply 376. PubMed ID: 16373783
    [No Abstract]   [Full Text] [Related]  

  • 5. Breast cancer in limited-resource countries: diagnosis and pathology.
    Shyyan R; Masood S; Badwe RA; Errico KM; Liberman L; Ozmen V; Stalsberg H; Vargas H; Vass L;
    Breast J; 2006; 12 Suppl 1():S27-37. PubMed ID: 16430396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine needle aspiration cytology versus percutaneous biopsy of nonpalpable breast lesions.
    Meunier M; Clough K
    Eur J Radiol; 2002 Apr; 42(1):10-6. PubMed ID: 12039016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective use of image-guided large-core needle biopsy of the breast: accuracy and cost-effectiveness.
    Doyle AJ; Murray KA; Nelson EW; Bragg DG
    AJR Am J Roentgenol; 1995 Aug; 165(2):281-4. PubMed ID: 7618540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging-guided core biopsies in the breast.
    Soo MS
    South Med J; 1998 Nov; 91(11):994-1000. PubMed ID: 9824178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in recall, biopsy, and positive biopsy rates for screening mammography in an academic practice.
    Gur D; Wallace LP; Klym AH; Hardesty LA; Abrams GS; Shah R; Sumkin JH
    Radiology; 2005 May; 235(2):396-401. PubMed ID: 15770039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effective use of breast biopsy techniques in a Veterans health care system.
    Hatmaker AR; Donahue RM; Tarpley JL; Pearson AS
    Am J Surg; 2006 Nov; 192(5):e37-41. PubMed ID: 17071179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A quest for quality and economic effectiveness throughout the continuum of breast care.
    La Fargue MM; Coleman C
    Breast; 2010 Aug; 19(4):251-2. PubMed ID: 20392641
    [No Abstract]   [Full Text] [Related]  

  • 12. The relative economics of screening for colorectal cancer, breast cancer and cervical cancer.
    Gyrd-Hansen D
    Crit Rev Oncol Hematol; 1999 Nov; 32(2):133-44. PubMed ID: 10612013
    [No Abstract]   [Full Text] [Related]  

  • 13. Needle core biopsy guided with mammography: a study of cost-effectiveness.
    Lindfors KK; Rosenquist CJ
    Radiology; 1994 Jan; 190(1):217-22. PubMed ID: 8259408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technology assessment: a perspective from the National Cancer Institute.
    Shtern F
    Acad Radiol; 1996 Apr; 3 Suppl 1():S84-7. PubMed ID: 8796524
    [No Abstract]   [Full Text] [Related]  

  • 15. The cost-effectiveness of fine-needle aspiration cytology and 14-gauge core needle biopsy compared with open surgical biopsy in the diagnosis of breast carcinoma.
    Logan-Young W; Dawson AE; Wilbur DC; Avila EE; Tomkiewicz ZM; Sheils LA; Laczin JA; Taylor AS
    Cancer; 1998 May; 82(10):1867-73. PubMed ID: 9587118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cost-effectiveness analysis of breast cancer screening with mammography].
    Iinuma T
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():226-8. PubMed ID: 17682158
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness of stereotactic core needle biopsy: analysis by means of mammographic findings.
    Lee CH; Egglin TK; Philpotts L; Mainiero MB; Tocino I
    Radiology; 1997 Mar; 202(3):849-54. PubMed ID: 9051045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammography and beyond: building better breast cancer screening tests.
    Wang L
    J Natl Cancer Inst; 2003 Mar; 95(5):344-6. PubMed ID: 12618493
    [No Abstract]   [Full Text] [Related]  

  • 20. Utilization and cost of diagnostic imaging and biopsies following positive screening mammography in the southern breast cancer screening region of the Netherlands, 2000-2005.
    Duijm LE; Groenewoud JH; Fracheboud J; Plaisier ML; Roumen RM; van Ineveld BM; van Beek M; de Koning HJ
    Eur Radiol; 2008 Nov; 18(11):2390-7. PubMed ID: 18491102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.